Benign Prostatic Hyperplasia clinical trials at UCSF
1 in progress, 0 open to eligible people
Sorry, in progress, not accepting new patients
This is a pilot 12-week randomized, placebo-controlled N-of-1 deprescribing trial among older men receiving chronic tamsulosin therapy for lower urinary tract symptoms attributed to benign prostatic hyperplasia.
San Francisco, California